How many drugs treat Vertigo?

Drug Landscape tracks 3 marketed treatments for Vertigo (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/vertigo.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Vertigo — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vertigo (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Vertigo, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Dimenhydrinate	DIMENHYDRINATE	Alra	dimenhydrinate	Histamine H1 receptor	1972-01-01
Antivert	meclizine	Generic (originally Pfizer/UCB)	Antihistamine/Antiemetic (vestibular suppressant)	Nuclear receptor subfamily 1 group I member 3, Serine protease hepsin, Histamine H1 receptor	1957-01-01
Antivert	meclozine	Citron Pharma Llc	Antiemetic	Nuclear receptor subfamily 1 group I member 3	1957-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Vertigo
Alra · 1 drug in Vertigo
Citron Pharma Llc · 1 drug in Vertigo
Generic (originally Pfizer/UCB) · 1 drug in Vertigo

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Vertigo:

Cite this brief

Drug Landscape (2026). Vertigo — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/vertigo. Accessed 2026-06-10.

Vertigo full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing